Publisher: DelveInsight
Category: Pharmaceuticals

Pharmaceuticals market research reports by DelveInsight

(4,761 reports matching your criteria)
    • Testicular cancer – Market Insight, Epidemiology, and Market Forecast – 2034

      Testicular cancer – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Testicular cancer – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Testicular cancer, historical and forecasted epidemiology as well as the Test ... Read More

    • Turner Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034

      Turner Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Turner Syndrome – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Turner Syndrome, historical and forecasted epidemiology as well as the Turner Syn ... Read More

    • Vertigo – Market Insight, Epidemiology, and Market Forecast – 2034

      Vertigo – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Vertigo – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Vertigo, historical and forecasted epidemiology as well as the Vertigo market trends in the Unite ... Read More

    • X Linked Hypophosphatemia – Market Insight, Epidemiology, and Market Forecast – 2034

      X Linked Hypophosphatemia – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""X Linked Hypophosphatemia – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the X Linked Hypophosphatemia, historical and forecasted epidemio ... Read More

    • Hypersomnia – Market Insight, Epidemiology, and Market Forecast – 2034

      Hypersomnia – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Hypersomnia – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Hypersomnia, historical and forecasted epidemiology as well as the Hypersomnia market tre ... Read More

    • Hypovolemic Shock – Market Insight, Epidemiology, and Market Forecast – 2034

      Hypovolemic Shock – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Hypovolemic Shock – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Hypovolemic Shock, historical and forecasted epidemiology as well as the Hypo ... Read More

    • Mucopolysaccharidosis – Market Insight, Epidemiology, and Market Forecast – 2034

      Mucopolysaccharidosis – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Mucopolysaccharidosis – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Mucopolysaccharidosis, historical and forecasted epidemiology as well ... Read More

    • Nonalcoholic Steatohepatitis (NASH) – Market Insight, Epidemiology, and Market Forecast – 2034

      Nonalcoholic Steatohepatitis (NASH) – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Nonalcoholic Steatohepatitis (NASH) – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Nonalcoholic Steatohepatitis (NASH), hist ... Read More

    • Bone Resorption – Market Insight, Epidemiology, and Market Forecast – 2034

      Bone Resorption – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Bone Resorption – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Bone Resorption, historical and forecasted epidemiology as well as the Bone Resor ... Read More

    • BRAF-Mutant Metastatic Melanoma – Market Insight, Epidemiology, and Market Forecast – 2034

      BRAF-Mutant Metastatic Melanoma – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""BRAF-Mutant Metastatic Melanoma – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the BRAF-Mutant Metastatic Melanoma, historical and f ... Read More

    • Autoimmune Uveitis – Market Insight, Epidemiology, and Market Forecast – 2034

      Autoimmune Uveitis – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Autoimmune Uveitis – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Autoimmune Uveitis, historical and forecasted epidemiology as well as the A ... Read More

    • Diabetic Neuropathic Pain- Pipeline Insight, 2024

      Diabetic Neuropathic Pain- Pipeline Insight, 2024 DelveInsight’s, “Diabetic Neuropathic Pain- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Diabetic Neuropathic Pain pipeline landscape. It covers the pipeline drug profiles, including cli ... Read More

    • Ovarian Granulosa Cell Tumors – Market Insight, Epidemiology, and Market Forecast – 2034

      Ovarian Granulosa Cell Tumors – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Ovarian Granulosa Cell Tumors – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Ovarian Granulosa Cell Tumors, historical and forecas ... Read More

    • Sickle Cell Disease - Epidemiology Forecast - 2034

      Sickle Cell Disease - Epidemiology Forecast - 2034 Key Highlights In 2023, the United States accounted for the highest number of total prevalent cases of SCD trait with approximately 54% cases found in the 6MM. The prevalence of SCD cases was found to be high and rapidly increasing in the 6MM countr ... Read More

    • Alopecia Areata- Pipeline Insight, 2024

      Alopecia Areata- Pipeline Insight, 2024 DelveInsight’s, “Alopecia Areata- Pipeline Insight, 2024” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Alopecia Areata pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pr ... Read More

    • Hemophilia B - Pipeline Insight, 2024

      Hemophilia B - Pipeline Insight, 2024 DelveInsight’s, “Hemophilia B - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Hemophilia Bpipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More

    • Lewy Body Disease - Pipeline Insight, 2024

      Lewy Body Disease - Pipeline Insight, 2024 DelveInsight’s, “Lewy Body Disease - Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Lewy Body Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More

    • Anterior Uveitis - Pipeline Insight, 2024

      Anterior Uveitis - Pipeline Insight, 2024 DelveInsight’s, “Anterior Uveitis - Pipeline Insight, 2024” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Anterior Uveitispipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More

    • Fragile X Syndrome - Pipeline Insight, 2024

      Fragile X Syndrome - Pipeline Insight, 2024 DelveInsight’s, “Fragile X Syndrome - Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Fragile X Syndromepipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinic ... Read More

    • Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024

      Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024 DelveInsight’s, “Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Primary Progressive Multiple Sclerosis pipeline landscape. It covers t ... Read More

    • 5-Alpha Reductase Inhibitor - Pipeline Insight, 2024

      5-Alpha Reductase Inhibitor - Pipeline Insight, 2024 “5-Alpha Reductase Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-Alpha Reductase Inhibitor development. The report p ... Read More

    • Transverse Myelitis - Pipeline Insight, 2024

      Transverse Myelitis - Pipeline Insight, 2024 Transverse Myelitis Overview ""Transverse Myelitis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Transverse Myelitis market. A detailed picture of th ... Read More

    • 5-HT2B Antagonist - Pipeline Insight, 2024

      5-HT2B Antagonist - Pipeline Insight, 2024 “5-HT2B Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2B Antagonist development. The report provides detailed coverage of t ... Read More

    • 20s Proteasome Inhibitor - Pipeline Insight, 2024

      20s Proteasome Inhibitor - Pipeline Insight, 2024 “20s Proteasome Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 20s Proteasome Inhibitor development. The report provides d ... Read More

    • 5-HT6 Antagonist - Pipeline Insight, 2024

      5-HT6 Antagonist - Pipeline Insight, 2024 “5-HT6 Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT6 Antagonist development. The report provides detailed coverage of the ... Read More

44 45 46 47 48 49 50

Cookie Settings